STOCK TITAN

Schrödinger to Participate in Five Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) announced its participation in several upcoming investor conferences. Notable events include the 33rd Annual Piper Sandler Virtual Healthcare Conference, the 4th Annual Evercore ISI HealthCONx Conference on November 30, 2021, and the BMO 2021 Growth & ESG Conference on December 7, 2021. Management will also engage in one-on-one meetings during the Berenberg Discover AI Seminar 2021 on December 1. Interested parties can access both live and archived webcasts through the investors section of Schrödinger's website.

Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate virtually at the following investor conferences:

  • 33rd Annual Piper Sandler Virtual Healthcare Conference: A pre-recorded fireside chat will be available today after 10:00 a.m. ET.
  • 4th Annual Evercore ISI HealthCONx Conference: Management will participate in a fireside chat on Tuesday, November 30, 2021, at 4:20 p.m. ET.
  • BMO 2021 Growth & ESG Conference: A fireside chat will take place on Tuesday, December 7th at 1:00 p.m. ET.
  • Goldman Sachs Byte-ology: The Convergence of Biotechnology and Technology: A Biotech panel will take place on Thursday, December 9, 2021, at 10:00 a.m. ET.

Additionally, the company will participate in one-on-one meetings during the Berenberg Discover AI Seminar 2021 on Wednesday, December 1st.

The live and pre-recorded webcasts can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately seven days.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, our blog www.extrapolations.com, or follow us on LinkedIn and Twitter.

Jaren Irene Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Tracy Lessor

Schrödinger, Inc.

tracy.lessor@schrodinger.com

617-519-9827

Source: Schrödinger

FAQ

What investor conferences will Schrödinger (SDGR) participate in November 2021?

Schrödinger will participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference on November 30, 2021.

When is Schrödinger's fireside chat at the BMO 2021 Growth & ESG Conference?

Schrödinger's fireside chat at the BMO 2021 Growth & ESG Conference is scheduled for December 7, 2021, at 1:00 p.m. ET.

How can I access the webcasts for Schrödinger's conferences?

The live and pre-recorded webcasts for Schrödinger's conferences can be accessed under 'News & Events' in the investors section of its website.

What other events will Schrödinger participate in besides investor conferences?

In addition to investor conferences, Schrödinger will have one-on-one meetings during the Berenberg Discover AI Seminar 2021 on December 1, 2021.

What is the purpose of Schrödinger's participation in these conferences?

Schrödinger aims to discuss its physics-based software platform that transforms the discovery of therapeutics and materials during these conferences.

Schrodinger, Inc.

NASDAQ:SDGR

SDGR Rankings

SDGR Latest News

SDGR Stock Data

1.39B
63.63M
2.39%
95.49%
12.14%
Health Information Services
Pharmaceutical Preparations
Link
United States of America
NEW YORK